Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Fellous

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
The New England Journal of Medicine|March 7, 2014
Mutant cohesin in premature ovarian failureSandrine Caburet, Valerie A Arboleda, Elena Llano, et al.
The American Journal of Bioethics : AJOB|December 4, 2015
Genome Editing and Dialogic Responsibility: "What's in a Name?"Alessandro Blasimme, Ignacio Anegon, Jean-Paul Concordet, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2012
North African Jewish and non-Jewish populations form distinctive, orthogonal clustersChristopher L Campbell, Pier F Palamara, Maya Dubrovsky, et al.
European Journal of Endocrinology|April 29, 2006
Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failurePaul Laissue, Sophie Christin-Maitre, Philippe Touraine, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 20, 2012
CITED2 mutations potentially cause idiopathic premature ovarian failureDora Janeth Fonseca, Diego Ojeda, Besma Lakhal, et al.
Cancers|November 7, 2020
Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative AnalysisAntoine Italiano, Shivani Nanda, Andrew Briggs, et al.
BMC Cancer|June 7, 2022
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinibJames C H Yang, Marcia S Brose, Gilberto Castro, et al.
Open Biology|November 3, 2016
Association of FOXD1 variants with adverse pregnancy outcomes in mice and humansPaul Laissue, Besma Lakhal, Magalie Vatin, et al.
The New England Journal of Medicine|February 25, 2026
Phase 1 Study of Rezatapopt, a p53 Reactivator, in <i>TP53</i> Y220C-Mutated TumorsEcaterina E Dumbrava, Geoffrey I Shapiro, Aparna R Parikh, et al.
European Journal of Human Genetics : EJHG|June 26, 2003
CATSPER2, a human autosomal nonsyndromic male infertility geneNili Avidan, Hannah Tamary, Orly Dgany, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
The New England Journal of Medicine|March 7, 2014
Mutant cohesin in premature ovarian failureSandrine Caburet, Valerie A Arboleda, Elena Llano, et al.
The American Journal of Bioethics : AJOB|December 4, 2015
Genome Editing and Dialogic Responsibility: "What's in a Name?"Alessandro Blasimme, Ignacio Anegon, Jean-Paul Concordet, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2012
North African Jewish and non-Jewish populations form distinctive, orthogonal clustersChristopher L Campbell, Pier F Palamara, Maya Dubrovsky, et al.
European Journal of Endocrinology|April 29, 2006
Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failurePaul Laissue, Sophie Christin-Maitre, Philippe Touraine, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 20, 2012
CITED2 mutations potentially cause idiopathic premature ovarian failureDora Janeth Fonseca, Diego Ojeda, Besma Lakhal, et al.
Cancers|November 7, 2020
Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative AnalysisAntoine Italiano, Shivani Nanda, Andrew Briggs, et al.
BMC Cancer|June 7, 2022
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinibJames C H Yang, Marcia S Brose, Gilberto Castro, et al.
Open Biology|November 3, 2016
Association of FOXD1 variants with adverse pregnancy outcomes in mice and humansPaul Laissue, Besma Lakhal, Magalie Vatin, et al.
The New England Journal of Medicine|February 25, 2026
Phase 1 Study of Rezatapopt, a p53 Reactivator, in <i>TP53</i> Y220C-Mutated TumorsEcaterina E Dumbrava, Geoffrey I Shapiro, Aparna R Parikh, et al.
European Journal of Human Genetics : EJHG|June 26, 2003
CATSPER2, a human autosomal nonsyndromic male infertility geneNili Avidan, Hannah Tamary, Orly Dgany, et al.
Pageof 14